Monopar Therapeutics (MNPR) — Net Income

Annual figures by fiscal year, from SEC filings.

2016: -$1.19M2017: -$16.55M2018: -$3.23M2019: -$4.22M2020: -$6.30M2021: -$9.10M2022: -$10.52M2023: -$8.40M2024: -$15.59M2025: -$13.72M-$13.72M
2016Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$13.72M+12.0%
2024-$15.59M-85.5%
2023-$8.40M+20.1%
2022-$10.52M-15.5%
2021-$9.10M-44.4%
2020-$6.30M-49.2%
2019-$4.22M-30.9%
2018-$3.23M+80.5%
2017-$16.55M-1296.3%
2016-$1.19M